Piper Jaffray Sees Increased Chance of Trius (TSRX) Partnering in Europe Following Tedizolid Data
Go back to Piper Jaffray Sees Increased Chance of Trius (TSRX) Partnering in Europe Following Tedizolid Data| TRIUS THERAPEUTICS (NASDAQ: TSRX) | Delayed: 13.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.63 | 52 Week High | $14.17 | |||
| Open | $13.63 | 52 Week Low | $4.41 | |||
| Day High | $13.63 | P/E | N/A | |||
| Day Low | $13.63 | EPS | $-1.61 | |||
| Volume | 91,764 | |||||
